Skip to main content
Clinical Trials/TCTR20240320003
TCTR20240320003
Recruiting
Phase 2

Effectiveness of Hyperbaric Oxygen Therapy and Conventional Treatment Versus Conventional Treatment Alone in Patients with Frozen Shoulder ; a Multicenter Randomized Controlled Trial.

Queen Sirikit Naval Hospital0 sites60 target enrollmentMarch 20, 2024

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Frozen shoulder.
Sponsor
Queen Sirikit Naval Hospital
Enrollment
60
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 20, 2024
End Date
September 12, 2025
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Queen Sirikit Naval Hospital

Eligibility Criteria

Inclusion Criteria

  • 1\. Diagnosis of frozen shoulder
  • 2\. Be diagnosed both before and after ethical approval of this proposal, from any primary doctor.
  • 3\. Onset of shoulder pain at least 2 months and not more than 9 months, as a first phase of frozen shoulder.
  • 4\. Normal radiographic study.
  • 5\. Consent to join the study.
  • 6\. Able to continue treatment protocol for 5 days.

Exclusion Criteria

  • 1\. History of previous shoulder trauma.
  • 2\. History of previous shoulder surgery.
  • 3\. History of previous shoulder infection.
  • 4\. History of inflammatory joint disease.
  • 5\. History of malignant.
  • 6\. History of shoulder injection with corticosteroids or nonsteroidal anti\-inflammatory drugs (NSAIDs)
  • 7\. Contraindication to hyperbaric oxygen therapy such as untreated pneumothorax, lung cyst, and uncontrolled seizure.
  • 8\. Allergy or contraindication to nonsteroidal anti\-inflammatory drugs (NSAIDs) or omeprazole such as gastrointestinal bleeding, chronic kidney disease, chronic liver disease, and current aspirin use from other medical condition.

Outcomes

Primary Outcomes

Not specified

Similar Trials